DOX DOX
Company Profile ↓Company Overview
DOX (DOX) is a publicly traded company listed on with a market capitalization of $16.05B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 16.5%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 16.6%.
Trades at an undemanding P/E of 10.9.
Operating margin of 17.9% supports profitability.
Carries low leverage with a debt-to-equity ratio of 0.24.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Sep 2025 Revenue of $4.53B (-9.4% YoY); net profit $564.70M.
- Trailing 12 Months Year-on-year growth — revenue -9.4%, earnings +14.5%.
- 5-Year Trend Long-term compounding — revenue CAGR -0.3%, profit CAGR 0.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -0.32% |
| 1 Year: | -9.43% |
Compounded Profit Growth
| 5 Years: | 0.91% |
| 1 Year: | 14.50% |
Stock Price Performance
| 1 Year: | -33.31% |
| 6 Months: | -23.80% |
| 3 Months: | -14.57% |
| 1 Month: | +5.74% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)54.71 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
CONS
- Revenue declined at -0.3% CAGR over 5 years.
- Trading 36.1% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 1.13B | 1.14B | 1.15B | 1.16B | 1.17B |
| Cost of Revenue | - | 698.05M | 711.15M | 719.88M | 727.72M | 716.73M |
| Gross Profit | - | 430.15M | 433.29M | 430.34M | 428.22M | 455.25M |
| Operating Expenses | - | 232.42M | 230.82M | 223.96M | 210.23M | 261.99M |
| Operating Income | - | 197.74M | 202.47M | 206.38M | 217.98M | 193.26M |
| EBITDA | - | 245.23M | 250.47M | 189.62M | 257.42M | 235.87M |
| Interest Expense | - | 8.46M | 11.71M | 15.86M | 11.27M | 5.96M |
| Pretax Income | - | 189.27M | 190.76M | 120.78M | 195.42M | 176.89M |
| Tax Provision | - | 25.27M | 35.96M | 23.67M | 36.96M | 38.12M |
| Net Income | - | 163.24M | 154.00M | 96.33M | 157.57M | 137.81M |
| Diluted EPS | - | 1.45 | 1.39 | 0.88 | 1.45 | 1.28 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Revenue | - | 4.58B | 4.89B | 5.00B | 4.53B |
| Cost of Revenue | - | 2.96B | 3.16B | 3.25B | 2.81B |
| Gross Profit | - | 1.62B | 1.73B | 1.76B | 1.72B |
| Operating Expenses | - | 954.35M | 1.00B | 995.70M | 909.38M |
| Operating Income | - | 664.80M | 724.89M | 759.70M | 812.20M |
| EBITDA | - | 889.85M | 857.41M | 821.20M | 931.11M |
| Interest Expense | - | 16.91M | 23.09M | 34.89M | 42.44M |
| Pretax Income | - | 648.41M | 636.36M | 591.07M | 693.24M |
| Tax Provision | - | 98.91M | 93.40M | 94.75M | 125.47M |
| Net Income | - | 549.50M | 540.71M | 493.20M | 564.70M |
| Diluted EPS | - | 4.44 | 4.49 | 4.25 | 5.05 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 6.39B | 6.43B | 6.39B | 6.25B |
| Current Assets | - | 2.00B | 1.91B | 1.77B | 1.59B |
| Cash & Equivalents | - | 573.38M | 520.08M | 346.08M | 325.00M |
| Inventory | - | - | - | - | - |
| Receivables | - | 789.61M | 732.98M | 665.74M | 589.78M |
| Total Liabilities | - | 2.83B | 2.86B | 2.89B | 2.78B |
| Current Liabilities | - | 1.25B | 1.35B | 1.47B | 1.36B |
| Long Term Debt | - | 645.12M | 645.70M | 646.29M | 646.90M |
| Total Debt | - | 826.83M | 807.31M | 789.74M | 826.40M |
| Total Equity | - | 3.52B | 3.52B | 3.46B | 3.43B |
| Shares Outstanding | - | 284.40M | 286.33M | 288.48M | 290.35M |
Cash Flows (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 756.72M | 822.63M | 724.43M | 749.10M |
| Investing Cash Flow | - | -262.50M | -224.50M | -127.41M | -2.06M |
| Financing Cash Flow | - | -629.90M | -651.43M | -771.02M | -768.12M |
| Capital Expenditure | - | -227.22M | -124.36M | -105.50M | -103.95M |
| Free Cash Flow | - | 529.50M | 698.27M | 618.93M | 645.14M |
| Net Change in Cash | - | -135.69M | -53.30M | -174.00M | -21.09M |
Ratios (Annual)
Figures in %.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 35.4% | 35.3% | 35.1% | 38.0% |
| Operating Margin % | - | 14.5% | 14.8% | 15.2% | 17.9% |
| Net Margin % | - | 12.0% | 11.1% | 9.9% | 12.5% |
| ROE % | - | 15.6% | 15.3% | 14.3% | 16.5% |
| ROCE % | - | 12.9% | 14.3% | 15.5% | 16.6% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for DOX
Here's What Key Metrics Tell Us About Amdocs (DOX) Q3 Earnings
The headline numbers for Amdocs (DOX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.…
Amdocs (DOX) Q3 Earnings Match Estimates
Amdocs (DOX) delivered earnings and revenue surprises of 0.00% and -0.04%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Cielo Selects Amdocs to Bring Intelligent Connectivity to Its Entire Brazilian Payment Terminal Network
Amdocs Remote eSIM Manager, part of the Amdocs eSIM Cloud Platform, empowers Cielo to deliver intelligent, software-defined connectivity across Brazil's payment ecosystem JERSEY CITY, NJ / ACCESS Newswire / August 5, 2026 / Amdocs (NASDAQ:D…
Optimum Transforms Customer Bill Experience with AI-Enhanced Platform Powered by Amdocs aOS Cognitive Core
Digital first, agentic experience simplifies billing to provide greater transparency, less confusion, and stronger self-service JERSEY CITY, NJ / ACCESS Newswire / August 5, 2026 / Amdocs (NASDAQ:DOX), a leading provider of software and ser…
Lumen Extends Multi-Cloud Strategy with Amdocs, Modernizing Enterprise Service Orchestration
aOS, Amdocs' agentic operating system for telco, will help modernize Lumen's enterprise service orchestration and order management platform on AWS, accelerating service innovation JERSEY CITY, NJ / ACCESS Newswire / August 5, 2026 / Amdocs …
PLDT Home Selects Amdocs to Modernize Core Business Platform, Advancing Cloud-Ready Transformation
Upgrade will boost business agility, streamline customer operations and establish a scalable foundation for future digital innovation JERSEY CITY, NJ / ACCESS Newswire / August 5, 2026 / Amdocs (NASDAQ:DOX), a leading provider of software a…
DOX — Frequently Asked Questions
What is the current share price of DOX?
As of 2026-08-05 17:25 PDT, DOX trades at $55.29 on NASDAQ/NYSE. Its 52-week range is $49.32 to $86.51.
What is the market capitalisation of DOX?
DOX has a market capitalisation of $16.05B on NASDAQ/NYSE.
What is the P/E ratio of DOX?
DOX trades at a trailing price-to-earnings (P/E) ratio of 10.95. Its price-to-book (P/B) ratio is 4.68.
What is the return on equity (ROE) of DOX?
DOX has a return on equity (ROE) of 16.47%. Its return on capital employed (ROCE) is 16.61%.
Is DOX a good stock to buy?
This page provides a data-driven analysis of DOX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.